GLPwatch
Papers (10386)
Page 132 of 174, ranked by citation count.
- Clinical experience with exenatide in a routine secondary care diabetes clinic.
- Oral Semaglutide: A Step Forward in Cardiovascular Risk Management for Type 2 Diabetes.
- The vascular function effects of adding exenatide or meal insulin to basal insulin therapy in early type 2 diabetes.
- Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT-MAINTAIN.
- The Association of British Clinical Diabetologists nationwide exenatide and liraglutide audits suggest a low incidence of acute pancreatitis. Response to Robson. Incretins and pancreatitis--what happens next? A personal viewpoint.
- Advancing Diabetes Management and Glycemic Control While Exploring CagriSema's Impact on Obesity Management.
- Association of Dulaglutide Initiation Timing With Treatment Patterns and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus in the United States.
- Indirect comparison of efficacy and safety of insulin glargine/lixisenatide and insulin degludec/insulin aspart in type 2 diabetes patients not controlled on basal insulin.
- Impact of GLP-1 and GLP-1/GIP agonists on healthcare resource utilization in individuals with scarring alopecias: A retrospective cohort analysis using TriNetX.
- People With Lowest Physical Functioning Scores Showed Greatest Improvement After Tirzepatide Treatment.
- Tirzepatide for the treatment of adults living with concurrent type 1 diabetes and overweight or obesity (TZP-T1D): a double-blind, placebo-matched randomised controlled trial protocol.
- Single dose and repeated administrations of liraglutide alter energy metabolism in the brains of young and adult rats.
- Multi-omics analysis of hepatic outcomes in T2DM-MAFLD patients treated with semaglutide: a single-centre, longitudinal, data-driven study.
- [Protective effect of glucagon-like peptide-1 analogue on cardiomyocytes injury induced by hypoxia/reoxygenation].
- A real-world study of tirzepatide for weight loss in adults without diabetes mellitus.
- Real-life use of liraglutide 3 mg in obesity management: The SAX-RL study.
- Impact of Fasting on Physical Activity Motivation and Weight Reduction in Patients Administered Glucagon-Like Peptide-1 Agonists: A Qualitative Study.
- Treatment of Metabolic (Dysfunction)-Associated Fatty Liver Disease: Evidence from Randomized Controlled Trials-A Short Review.
- Diabetes Mellitus and Cardiovascular Disease: An Evidence-Based Review of Provincial Formulary Coverage.
- The Effect of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists on the Lipid Profile of Diabetic Patients Using Statins: A Retrospective Cohort Study in the Diabetic Center of King Salman Bin Abdulaziz Hospital, Saudi Arabia.
- Achieving normoglycaemia with tirzepatide: Post hoc exploratory analysis of the SURPASS J-mono and J-combo studies.
- Exploring the Effects of Tirzepatide on Obstructive Sleep Apnea: A Literature Review.
- Dulaglutide use to improve binge eating behaviors in a person with type 2 diabetes and obesity.
- Tirzepatide Therapy in a Patient with Type 2 Diabetes Mellitus, Chylomicronemia, and Heterozygosity for Lipoprotein Lipase Deficiency.
- Exendin-4 protects the dopaminergic neurons by attenuating inflammatory responses of microglial cells via activation of AMPK.
- Dual-phase exenatide delivery system: PLGA nanoparticles embedded in thermosensitive PLGA-PEG-PLGA hydrogel for sustained glycemic control.
- Tirzepatide Lowered Blood Pressure in People With Obesity.
- Semaglutide - properties, action and chromatographic analysis.
- Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review.
- Effects of repeated developmental GLP-1R agonist exposure on young adult behavior and hippocampal structure in mice.
- Liraglutide in type 2 diabetes mellitus.
- Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model.
- [Glucagon-like peptide 1 receptor agonists for the treatment of Type 2 diabetes].
- The prospective record-breaking obesity drug tirzepatide raises concerns about affordability.
- Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review.
- Semaglutide and the pathogenesis of progressive neurodegenerative disease: the central role of mitochondria.
- Early resuscitation with exendin-4 alleviates acute lung injury after hemorrhagic shock in rats.
- Generalizability of results from the recent FDA-guided cardiovascular outcomes trials to a representative population with Type 2 Diabetes attending primary care clinics.
- Tirzepatide-Induced Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Presenting With Seizures.
- [The protective effect of exenatide on the renal injury in diabetic rats].
- Improved Clinical Outcomes with Dulaglutide as Add-on Medication to Oral Antidiabetic Drugs with or Without Insulin in Overweight Indian Patients with Type 2 Diabetes Mellitus: Retrospective Study in a Real-World Setting.
- Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?
- The prostaglandin E<sub>2</sub> EP3 receptor has disparate effects on islet insulin secretion and content in β-cells in a high-fat diet-induced mouse model of obesity.
- Tirzepatide-New Evidence for the Treatment of Obesity From China.
- Role of glucagon-like peptide-1 analogues on insulin receptor regulation in diabetic rat hearts.
- Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial.
- Real-world effectiveness and safety of tirzepatide in Japanese patients with type 2 diabetes: A multi-site retrospective study.
- The GLP-1 analog, exendin-4, improves bone material properties and strength through a central relay in ovariectomized mice.
- Design of experiments approach for the development of a validated method to determine the exenatide content in poly(lactide-co-glycolide) microspheres.
- GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis.
- [Dulaglutide (Trulicity®), a new once-weekly agonist of glucagon-like peptide-1 receptors for type 2 diabetes].
- Dulaglutide (Trulicity) for Type 2 Diabetes Mellitus.
- Use of liraglutide after bariatric surgery: a 36-month follow-up in a real-world setting in Chile.
- The effects of GLP-1 agonists on HbA1c and insulin dose among patients with type 1 diabetes.
- Surpassing insulin glargine in type 2 diabetes with tirzepatide.
- Answers to Clinical Questions in the Primary Care Management of People with Obesity: Pharmacologic Management.
- Clinical trials for adolescent obesity: cooking up an alphabet stew of what to do.
- Semaglutide, tirzepatide, and retatrutide attenuate the interoceptive effects of alcohol in male and female rats.
- Glucagon-like peptide-1 receptor agonists may decrease biologic initiation in hidradenitis suppurativa: A TriNetX retrospective analysis.
- Exenatide Induces Impairment of Autophagy Flux to Damage Rat Pancreas.